Yayoi Yoshinaga

ORCID: 0009-0007-2502-0824
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Healthcare Systems and Practices
  • Health, Medicine and Society
  • Liver Disease and Transplantation
  • Hepatitis Viruses Studies and Epidemiology
  • COVID-19 and Mental Health
  • Social and Demographic Issues in Germany
  • Liver Diseases and Immunity
  • Disaster Response and Management
  • TiO2 Photocatalysis and Solar Cells
  • Advanced Photocatalysis Techniques
  • Long-Term Effects of COVID-19
  • Catalytic Processes in Materials Science
  • Cardiac, Anesthesia and Surgical Outcomes
  • Child and Adolescent Health
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Viral gastroenteritis research and epidemiology

Hiroshima University
2024-2025

Yamaguchi University
2003

Abstract More than 200 million COVID-19 survivors have lasting symptoms after recovering, but the duration and related risk factors remain uncertain. This study focused on all 6551 patients diagnosed with at a medical institution in Hiroshima from March 2020 to July 2022. In November 2022, questionnaire survey was conducted regarding post-COVID their duration. The prevalence of were illustrated using Kaplan–Meier method. Risk for over 3 months interfering daily life assessed via multivariate...

10.1038/s41598-024-54397-y article EN cc-by Scientific Reports 2024-02-16

Abstract Aim To estimate the weighted prevalence of hepatitis E virus (HEV) antibodies and risk factors among pregnant women in Burkina Faso to evaluate efficiency dried blood spots (DBS) detecting HEV antibodies. Methods We first evaluated DBS by comparing 62 with matched serum samples using recomWell IgG IgM kits (Mikrogen Diagnostik). Anti‐HEV immunoglobulin G (IgG) M (IgM) were identified 491 collected from kits. RNA was tested nested polymerase chain reaction HEV‐antibodies positive....

10.1111/hepr.14180 article EN cc-by-nc-nd Hepatology Research 2025-03-12

Hepatitis E virus (HEV) is a major global health issue, with an estimated 20 million infections annually. Although polymerase chain reaction (PCR) the diagnostic gold standard due to its precision, it expensive and technically demanding. Antibody tests offer more practical cost-effective alternative, although their accuracy can vary factors, such as test manufacturer, antigen composition, HEV genotype, host immune status.

10.1111/hepr.14132 article EN cc-by-nc-nd Hepatology Research 2024-11-02
Coming Soon ...